Dottorato in Medicina Molecolare

Ferrero S, Ladetto M, Drandi D, Cavallo F, Genuardi E, Urbano M, Caltagirone S, Grasso M, Rossini F, Guglielmelli T, Cangialosi C, Liberati AM, Callea V, Carovita T, Crippa C, De Rosa L, Pisani F, Falcone AP, Pregno P, Oliva S, Terragna C, Musto P, Passera R, Boccadoro M, Palumbo A.

LONG-TERM RESULTS OF THE GIMEMA VEL-03-096 TRIAL IN MM PATIENTS RECEIVING VTD CONSOLIDATION AFTER ASCT: MRD KINETICS' IMPACT ON SURVIVAL.

Leukemia.  Jul 16. p. 1-7, (2014)

Mannu C, Gazzola A, Ciabatti E, Fuligni F, Cavalli M, Della Starza I, Genuardi E,Mantoan B, Monitillo L, Del Giudice I, Ladetto M, Gaidano G, Sabattini E, Pileri SA, Galimberti S, Piccaluga PP; on behalf of Fondazione Italiana Linfomi - MrdNetwork. COMPARISON OF DIFFERENT DNA EXTRACTION METHODS FROM PERIPHERAL BLOOD CELLS: ADVICES FROM THE FONDAZIONE ITALIANA LINFOMI - MRD NETWORK.

LeukLymphoma. 2014 Aug 12:1-23

Della Starza I, Cavalli M, Del Giudice I, Barbero D, Mantoan B, Genuardi E, Urbano M, Mannu C, Gazzola A, Ciabatti E, Guarini A, Foà R, Galimberti S, Piccaluga P, Gaidano G, Ladetto M, Monitillo L.

Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.

Hematol Oncol. 2013 Nov 19. doi: 10.1002/hon.2095. [Epub ahead of print]

Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, Boccomini C, Genuardi E, Chiappella A, Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto A, Galimberti S, Bari A, Rota-Scalabrini D, Ferrari A, Zaja F, Gallamini A, Specchia G, Musto P, Rossi FG, Gamba E, Evangelista A, Vitolo U.

Persistence of minimal residual disease in the bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.

Blood. 2013 Oct 1. [Epub ahead of print]

Ferrero S, Monitillo L, Mantoan B, Barbero D, Genuardi E, Barbiero S, Bernocco E, Caracciolo D, Ruella M, Drandi D, Zanni M, Renna F, Lobetti Bodoni C, Gueli A, Passera R, Musto P, Boccadoro M, Tarella C, Ladetto M.

Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma.

Ann Hematol. 2013 Nov;92(11):1503-11. doi: 10.1007/s00277-013-1797-y. Epub 2013 Jun 5.

Lobetti-Bodoni C, Mantoan B, Monitillo L, Genuardi E, Drandi D, Barbero D, Bernocco E,
Boccadoro M, Ladetto M.
CLINICAL IMPLICATIONS AND PROGNOSTIC ROLE OF MINIMAL RESIDUAL DISEASE
DETECTION IN FOLLICULAR LYMPHOMA.
Ther Adv Hematol. 2013 Jun;4(3):189-98

Lobetti-Bodoni C, Ferrero D, Genuardi E, Passera R, Bernocco E, Sia D, Grignani G, Crisà E,
Monitillo L, Rocci A, Drandi D, Giai V, Zanni M, Boi M, Isaia G, Barbero D, Lunghi M, Abruzzese
E, Radaelli F, Pini M, Pregno P, Carlo-Stella C, Gaidano G, Boccadoro M, Ladetto M.
TELOMERE LOSS IN PHILADELPHIA-NEGATIVE HEMATOPOIESIS AFTER SUCCESSFUL
TREATMENT OF CHRONIC MYELOID LEUKEMIA: EVIDENCE FOR PREMATURE AGING OF
THE MYELOID COMPARTMENT.
Mech Ageing Dev. 2012 Jul;133(7):479-88. doi: 10.1016/j.mad.2012.05.007. Epub 2012 Jun 9

Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Cerri M, Deambrogi C, Drandi D, Rocci A,
Boi M, Ferrero S, Capello D, De Paoli L, Bergui L, Omedè P, Massaia M, Boccadoro M, Gaidano
G, Ladetto M.
“SHORT TELOMERE LENGTH IS AN INDEPENDENT PREDICTOR OF SURVIVAL,
PROGRESSION, RICHTER’S SYNDROME TRANSFORMATION AND RECURRENT
INFECTIONS: AN ANALYSIS ON 421 CLL PATIENTS INCLUDING BLINDED VALIDATION ON
230 CASES”.
Leukemia. 2009 Jun;23(6):1062-72.

Daniela Drandi, LenkaKubiczkova, Simone Ferrero, Nadia Dani, Roberto Passera, Barbara Mantoan, Manuela Gambella, Luigia Monitillo, ElonaSaraci, Paola Ghione , Elisa Genuardi, Daniela Barbero, Paola Omedè, Davide Barberio, Roman Hajek, Umberto Vitolo, Antonio Palumbo, Sergio Cortelazzo, Mario Boccadoro, Giorgio Inghirami, Marco Ladetto

droplet digital pcr (ddpcr) and real-time pcr (rq-pcr): a head to head comparison for MRD detection in myeloma (MM) mantle cell lymphoma (MCL) and follicular lymphoma (FL)

19th Congress of the European-Hematology-Association (EHA) Milan, ITALY , JUN 12-15, 2014

C. Pott , L. Monitillo , E. Genuardi, B. Mantoan, H. Trautmann, M. Kneba, M.
Brüggemann, M. Faham, M. Ladetto.
A comparative analysis of next-generation sequencing and real-time quantitative
PCR for minimal residual disease detection in follicular lymphoma
18th Congress of the European Hematology Association, June 13 - 16, 2013, Stockholm,
Sweden

 M. Ladetto, C. Lobetti-Bodoni, B. Mantoan, A. Evangelista, C. Boccomini, E. Genuardi,
A. Chiappella, L. Baldini, G. Rossi, A. Pulsoni, F. Di Raimondo, L. Rigacci, A. Pinto, S.
Galimberti, S. Sacchi, D. Rota-Scalabrini, F. Merli, G. Parvis, E. Gamba, U. Vitolo.
Minimal residual disease at multiple timepoints is a strong outcome predictor in
follicular lymphoma patients: results of the ml17638 trial of the fondazione italiana
linfomi
11th International Conference on Malignant Lymphoma (ICML), June 19- 22, 2013,
Lugano, Switzerland

S. Ferrero, M. Ladetto, D. Drandi, F. Cavallo, E. Genuardi, M. Urbano, G.Guarona, V.
Callea, C.Cangialosi, T. Caravita, , C. Crippa, L. De Rosa, A.P. Falcone, M. Grasso, T.
Guglielmelli, A.M. Liberati, F. Pisani, P. Pregno, F. Rossini, S. Oliva, A. Rocci, R. Passera,
M. Boccadoro and A. Palumbo.
Long-Term Molecular Results Of The Gimema VEL-03-096 Trial: Molecular
Remission Achievement and Loss Are Major Outcome Predictors
2013 ASH Annual Meeting and Exposition, December 7-10, 2013, New Orleans, LA.

D.Drandi, L. Kubiczkovà, N. Dani, S. Ferrero, L. Monitillo, B. Mantoan, E. Genuardi, D.
Barbero, M. Gambella, D. Barberio, P. Ghione, G. Guarona, E. Saraci, P. Omedè, R.
Passera, R. Hajek, S. Cortelazzo, A. Palumbo, M. Boccadoro, G. Inghirami and M.
Ladetto.
Improved Igh-Based MRD Detection By Using Droplet Digital PCR: a Comparison
With Real Time Quantitative PCR In MCL and MM
2013 ASH Annual Meeting and Exposition, December 7-10, 2013, New Orleans, LA.

C. Pott , L. Monitillo , E. Genuardi, B. Mantoan, H. Trautmann, M. Kneba, M.
Brüggemann, M. Faham, M. Ladetto.
A comparative analysis of next-generation sequencing and real-time quantitative
pcr for minimal residual disease detection in follicular lymphoma
2013 ASH Annual Meeting and Exposition, December 7-10, 2013, New Orleans, LA.

Ladetto M, Lobetti-Bodoni C, Mantoan B, Evangelista A, Boccomini C, Genuardi E, Botto B,
Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto, Petrini M, Sacchi S, Rota-
Scalabrini D, Gugliotta L, Fanin R, Gallamini A, Parvis G, Specchia G, Musto P, Olivero B,
Gamba E, Ciccone G and Vitolo U.
PCR-BASED MINIMAL RESIDUAL DISEASE (MRD) DETECTION IS A STRONG
INDEPENDENT OUTCOME PREDICTOR ALSO IN RITUXIMAB-INTENSIVE NON-ASCTBASED
PROGRAMS: RESULTS FROM THE ML17638 MULTICENTER RANDOMISED PHASE
III TRIAL FOR ELDERLY FOLLICULAR LYMPHOMA (FL) PATIENTS OF THE FONDAZIONE
ITALIANA LINFOMI (FIL).
BLOOD-54th Annual Meeting and Exposition of the American-Society-of-Hematology
(ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis- Dec 8-11, 2012
Atlanta, GA.

Genuardi E, Bernocco E, Rossi D, Lobetti-Bodoni C, Passera R, Ghione P, Bruna R, Drandi D,
Coscia M, Ruggeri M, Fangazio M, Monitillo L, Barbero D, Mantoan B, Barbiero S, Zanni M,
Gattei V, Bergui L, Omedè P, Massaia M, Boccadoro M, Gaidano G, Ladetto M.
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) EVOLUTION:
AN ANALYSIS ON 88 CASES.
HAEMATOLOGICA; THE HEMATOLOGY JOURNAL-17th Annual Meeting of the European-
Hematology-Association-Jun14-17, 2012 Amsterdam, Holland

Bernocco, E; Rossi, D; Genuardi, E; Lobetti-Bodoni, C; Passera, R; Drandi, D; Coscia, M;
Ruggeri, M; Fangazio, M; Ghione, P; Barbero, D; Mantoan, B; Barbiero, S; Zanni, M; Gattei, V;
Bergui, L; Omede, P; Massaia, M; Boccadoro, M; Gaidano, G; Ladetto, M
PROGRESSIVE TELOMERE SHORTENING IS PART OF THE NATURAL HISTORY OF
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND IMPACTS CLINICAL OUTCOME
BLOOD-53rd Annual Meeting and Exposition of the American-Society-of-Hematology
(ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis- Dec 10-13, 2011 San
Diego, CA

Genuardi E, Ruggeri M. , Drandi D., Caltagirone S., Mastrocola R., Bernocco E., Lobetti-Bodoni
C. , Boi M. , Monitillo L., Mantoan B, Mantella E., Isaia G., Bergui L., Coscia M., Boccadoro M,
Massaia M, Omedè P., Ladetto M.
TELOMERE LENGHT MEASUREMENT IN THE CLINICALLY ORIENTED RESEARCH setting:
a comparison between southern blot (SB), real time quantitative PCR (RQ-PCR) and Flow-Fish
(FF).
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 43°rd Congress of the Italian-Society-of-
Experimental-Hematology Oct 16-17 Napoli, ITALY

Genuardi E, Ruggeri M. , Drandi D., Caltagirone S., Mastrocola R., Bernocco E., Lobetti-Bodoni
C. , Boi M. , Monitillo L., Mantoan B, Mantella E., Isaia G., Bergui L., Coscia M., Boccadoro M,
Massaia M, Omedè P., Ladetto M.
TELOMERE LENGHT MEASUREMENT IN THE CLINICALLY ORIENTED RESEARCH
SETTING: A COMPARISON BETWEEN SOUTHERN BLOT (SB), REAL TIME QUANTITATIVE
PCR (RQ-PCR) AND FLOW-FISH (FF)
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 43°rd Congress of the Italian-Society-of-
Experimental-Hematology Oct 16-17 Napoli, ITALY

Barbero D, Drandi D, Lobetti Bodoni C, Bernocco E, Coscia M, Ruggeri M, Boi M, Genuardi E,
Monitillo L, Mantoan B, Maffeo C, Barbiero S, Ferrero S, Rossi D, Passera R, Gaidano G,
Massaia M, Omedè P, Boccadoro M, Ladetto M.
EXPRESSION OF TELOMERIC PROTEINS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 43°rd Congress of the Italian-Society-ofExperimental-Hematology Oct 16-17 Napoli, ITALY

Genuardi, E; Rossi, D; Bernocco, E; Bodoni, CL; Drandi, D; Coscia, M; Ruggeri, M; Fangazio,
M; Ghione, P; Gattei, V; Boccadoro, M; Omede, P; Massaia, M; Gaidano, G; Ladetto, M
PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF
CHRONIC LYMPHOCYTIC LEUKEMIA
ANNALS OF ONCOLOGY-11th International Conference on Malignant Lymphoma -Jun 15-18,
2011 Lugano, CH

Ferrero, S; Capello, D; Svaldi, M; Drandi, D; Boi, M; Barbiero, S; Gatti, D; Rossi, D; Genuardi,
E; Antico, O; Ghione, P; Zanni, M; Rocci, A; Bertoni, F; Zucca, E; Gattei, V; Palumbo, A;
Cortelazzo, S; Boccadoro, M; Gaidano, G; Ladetto, M
IGH REPERTOIRE ANALYSIS IN MULTIPLE MYELOMA (MM): LACK OF INTRA-DISEASE
HOMOLOGY AND OCCASIONAL CLUSTERING WITH SEQUENCES OF OTHER B-CELL
NEOPLASMS SHARING IDENTICAL GEOGRAPHICAL ORIGIN
BLOOD-52nd Annual Meeting of the American-Society-of-Hematology (ASH)-Dec 04-07, 2010
Orlando, FL

Bodoni, CL; Dario, F; Genuardi, E; Passera, R; Bernocco, E; Daniela, S; Crisa, E; Grignani, G;
Rocci, A; Monitillo, L; Drandi, D; Giai, V; Ferrero, S; Boi, M; Mantella, E; Isaia, G; Lunghi, M;
Abruzzese, E; Radaelli, F; Pini, M; Pregno, P; Carlo-Stella, C; Gaidano, G; Boccadoro, M;
Ladetto, M
SEVERE TELOMERIC EROSION IN PH-NEGATIVE HEMATOPOIESIS AFTER SUCCESSFUL
CML TREATMENT: ASSOCIATION WITH ACQUIRED CYTOGENETIC LESIONS AND
HEMATOLOGICAL TOXICITY
BLOOD-52nd Annual Meeting of the American-Society-of-Hematology (ASH)-Dec 04-07, 2010
Orlando, FL

Bodoni, CL; Ferrero, D; Genuardi, E; Sia, D; Genuardi, M; Giai, V; Rocci, A; Monitillo, L; Drandi,
D; Risso, A; Ferrero, S; Isaia, G; Lunghi, M; Passera, R; Gaidano, G; Boccadoro, M; Carlo-
Stella, C; Ladetto, M
PH-NEGATIVE HEMATOPOIESIS EMERGING AFTER SUCCESSFUL TREATMENT OF
CHRONIC MYELOGENOUS LEUKEMIA DYSPLAYS SEVERE AND PERSISTENT
TELOMERIC LOSS AND IMPAIRED FUNCTIONAL PERFORMANCES
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 14th Annual Meeting of the European-
Hematology-Association-Jun 04-07, 2009 Berlin, GERMANY

Rossi, D; Bodoni, CL; Genuardi, E; Monitillo, L; Drandi, D; Deambrogi, C; Cerri, M; Ricca, I;
Rocci, A; Ferrero, S; Bernocco, E; Capello, D; De Paoli, L; Bergui, L; Boi, M; Omede, P;
Massaia, M; Tarella, C; Passera, R; Boccadoro, M; Gaidano, G; Ladetto, M
TELOMERE LENGTH IS AN INDEPENDENT PREDICTOR OF SURVIVAL, TREATMENT
REQUIREMENT AND RICHTER'S SYNDROME TRANSFORMATION IN CHRONIC
LYMPHOCYTIC LEUKEMIA.
BLOOD 50th Annual Meeting of the American-Society-of-Hematology(ASH)-Dec 06-09, 2008
San Francisco, CA

Bodoni, CL; Ferrero, D; Genuardi, E; Sia, D; Genuardi, M; Giai, V; Rocci, A; Monitillo, L; Drandi,
D; Risso, A; Ferrero, S; Mantoan, B; Critelli, R; Bussano, S; Lunghi, M; Passera, R; Tarella, C;
Gaidano, G; Boccadoro, M; Carlo-Stella, C; Ladetto, M
PERSISTENT TELOMERIC LOSS AND FUNCTIONAL IMPAIRMENT OF PH-NEGATIVE
HEMATOPOIESIS AFTER SUCCESSFUL TREATMENT OF CHRONIC MYELOGENOUS
LEUKEMIA
BLOOD-50th Annual Meeting of the American-Society-of-Hematology(ASH)-Dec 06-09, 2008
San Francisco, CA

Lobetti, BC; Genuardi, E; Genuardi, M; Giai, V; Rocci, A; Monitillo, L; Drandi, D; Risso, A;
Mantoan, B; Ferrero, S; Critelli, R; Bernocco, E; Tarella, C; Boccadoro, M; Ferrero, D; Ladetto,
M.
MARKED TELOMERE EROSION OF PH-NEGATIVE MYELOID CELLS AFTER SUCCESSFUL
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA INDICATES SEVERE
PROLIFERATIVE STRESS AND POTENTIAL PERMANENT DAMAGE OF HEMATOPOIESIS
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 10th Congress of the Italian-Society-ofExperimental-Hematology Sep 24-26, 2008 Bari, ITALY

Rossi, D; Lobetti, BC; Genuardi, E; Monitillo, L; Cerri, M; Deambrogi, C; Drandi, D; Ricca, I;
Rocci, A; Boi, M; Ferrero, S; Capello, D; De Paoli, L; Bergui, L; Omede, P; Massaia, M;
Boccadoro, M; Gaidano, G; Ladetto, M
SHORT TELOMERE LENGTH IS AN INDEPENDENT PREDICTOR OF SURVIVAL,
PROGRESSION, RICHTER'S SYNDROME TRANSFORMATION AND RECURRENT
INFECTIONS: AN ANALYSIS ON 421 CLL PATIENTS INCLUDING BLINDED VALIDATION ON
230 CASES
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 10th Congress of the Italian-Society-of-
Experimental-Hematology,Sep 24-26, 2008 Bari, ITALY

Rossi, D; Bodoni, CL; Genuardi, E; Monitillo, L; Cerri, M; Deambrogi, C; Drandi, D; Ricca, I;
Rocci, A; Boi, M; Ferrero, S; Capello, D; De Paoli, L; Bergui, L; Omede, P; Massaia, M;
Boccadoro, M; Gaidano, G; Ladetto, M
SHORT TELOMERE LENGTH IS AN INDEPENDENT PREDICTOR OF SURVIVAL,
PROGRESSION, RICHTER'S SYNDROME TRANSFORMATION AND RECURRENT
INFECTIONS: AN ANALYSIS ON 421 CLL PATIENTS INCLUDING BLINDED VALIDATION ON
230 CASES
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 13th Congress of the European-
Hematology-Association Jun 12-15, 2008 Copenhagen, DENMARK

Ladetto, M; Bodoni, CL; Genuardi, E; Genuardi, M; Giai, V; Rocci, A; Monitillo, L; Drandi, D;
Risso, A; Mantoan, B; Ferrero, S; Critelli, R; Tarella, C; Boccadoro, M; Ferrero, D
MARKED TELOMERE EROSION OF PH-NEGATIVE MYELOID CELLS AFTER SUCCESSFUL
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA INDICATES SEVERE
PROLIFERATIVE STRESS AND POTENTIAL PERMANENT DAMAGE OF HEMATOPOIESIS
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 13th Congress of the European-
Hematology-Association JUN 12-15, 2008 Copenhagen, DENMARK

De Marco, E; Ladetto, M; Magni, M; Caracciolo, D; Mantoan, B; Pagliano, G; Drandi, D; Astolfi,
M; Boi, M; Genuardi, E; Critelli, R; Ferrero, S; Lobetti Bodoni, C; Zanni, M; Boccadoro, M;
Gianni, AM; Tarella, C
RITUXIMAB INDUCES EFFECTIVE CLEARANCE OF MINIMAL RESIDUAL DISEASE IN
MOLECULAR RELAPSES OF FOLLICULAR AND MANTLE CELL LYMPHOMA
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 41st Congress of the Italian-Society-of-
Hematology OCT 14-17, 2007 Bologna, ITALY

Ladetto, M; Astolfi, M; Santo, L; Avonto, I; Cavallo, F; Pagliano, G; Pregno, P; Grasso, M;
Liberati, AM; Caravita, T; Pisani, F; Guglielmelli, T; Genuardi, E; Crivelli, R; Cristiano, C;
Magarotto, V; D'Agostino, F; Drandi, D; Boccadoro, M; Palumbo, A CLINICAL AND
MOLECULAR RESULTS OF A POST-TRANSPLANT CONSOLIDATION WITH BORTEZOMIB,
THALIDOMIDE AND DEXAMETHASONE IN MULTIPLE MYELOMA
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 41st Congress of the Italian-Society-of-
Hematology OCT 14-17, 2007 Bologna, ITALY

Ladetto, M; Astolfi, M; Santo, L; Avonto, I; Cavallo, F; Pagliano, G; Pregno, P; Grasso, M;
Liberati, AM; Caravita, T; Pisani, F; Guglielmelli, T; Genuardi, E; Crivelli, R; Cristiano, C; Drandi,
D; Boccadoro, M; Palumbo, A
IMPACT OF CONSOLIDATION WITH BORTEZOMIB, THALIDOMIDE AND
DEXAMETHASONE ON RESIDUAL MULTIPLE MYELOMA CELLS AFTER AUTOLOGOUS
TRANSPLANTATION ASSESSED BY QUALITATIVE AND QUANTITATIVE PCR
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 12th Congress of the European-
Hematology-Association JUN 07-10, 2007 Vienna, AUSTRIA

Ladetto, M; Astolfi, M; Santo, L; Avonto, I; Cavallo, F; Pagliano, G; Pregno, P; Grasso, M;
Liberati, AM; Caravita, T; Pisani, F; Guglielmelli, T; Genuardi, E; Crivelli, R; Cristiano, C; Drandi,
D; Ferrero, S; Boccadoro, M; Palumbo, A
EARLY CONSOLIDATION WITH BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE ON
MOLECULARLY-DETECTABLE DISEASE IN MM PATIENTS IN CR OR VGPR FOLLOWING
ASCT: UNCOMMON ACHIEVEMENT OF MOLECULAR REMISSION DESPITE EVIDENCE OFTUMOUR LOAD REDUCTION BY REAL TIME PCR
BONE MARROW TRANSPLANTATION 33rd Annual Meeting of the European-Group-for-Bloodand-
Marrow-Transplantation MAR 25-28, 2007 Lyon, FRANCE

Ladetto, M; Astolfi, M; Santo, L; Avonto, I; Cavallo, F; Pagliano, G; Pregno, P; Grasso, M;
Liberati, AM; Caravita, T; Pisani, F; Guglielmelli, T; Genuardi, E; Crivelli, R; Cristiano, C; Drandi,
D; Boccadoro, M; Palumbo, A
IMPACT OF EARLY CONSOLIDATION WITH BORTEZOMIB, THALIDOMIDE AND
DEXAMETHASONE ON MOLECULARLY-DETECTABLE DISEASE IN MM PATIENTS IN CR
OR VGPR FOLLOWING AUTOLOGOUS TRANSPLANTATION: UNCOMMON ACHIEVEMENT
OF MOLECULAR REMISSION DESPITE EVIDENCE OF TUMOR LOAD REDUCTION BY
REAL TIME PCR.
BLOOD 48th Annual Meeting of the American-Society-of-HematologyDEC 09-12, 2006 Orlando,FL

 

 

20 novembre 2014- SIES Discutiamone Insieme - Firenze

17-18 novembre 2014–10°Quality control round of Minimal Residual Disease (MRD)

network. Policlinico Sant’Orsola e Malpighi- Bologna

12-13 novembre 2014- Illumina User Group Meeting- Milano

28 settembre-1 ottobre 2014- 9° EC-NGS Group Meeting- Rotterdam

5-6maggio2014- 9°Quality control round of Minimal Residual Disease (MRD)network. Ematologia Universitaria, Pisa.

11-13 aprile 2013 - Quality control round of Minimal Residual Disease (MRD)
network. Istituto di Ematologia, Università di Roma “Sapienza”
14 giugno 2013- Using new technologies to study the genetics of disease. ILLUMINA
EVENT, ASO San Luigi Gonzaga, Orbassano, Torino.
26 settembre 2013- Second Italian Clonality workshop: Case training –Discutiamone
insieme: I test di clonalità nei linfomi non Hodgkin. Policlinico S.Orsola Malpighi,
Bologna.
14-16 ottobre 2013- Quality control round of Minimal Residual Disease (MRD)
network. Ematologia Universitaria I, Città della Salute, Torino.
20-23 ottobre 2013- 44° Congresso Nazionale SIE- Società Italiana di Ematologia.
Verona.

14 Settembre 2012 - " D-day -  Scuola di Dottorato in Scienze della Vita e della Salute " 

4-5 Maggio 2012- Quality control round MRD network

26-27 Ottobre 2012- Quality control round MRD network

14 Dicembre 2012 - “VII Immunology and Cell Biology PhD Day”